No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure

被引:32
|
作者
Dass, Sairia [1 ]
Holloway, Cameron J. [2 ]
Cochlin, Lowri E. [2 ]
Rider, Oliver J. [1 ]
Mahmod, Masliza [1 ]
Robson, Matthew [1 ]
Sever, Emily [1 ]
Clarke, Kieran [2 ]
Watkins, Hugh [1 ]
Ashrafian, Houman [1 ]
Karamitsos, Theodoros D. [1 ]
Neubauer, Stefan [1 ]
机构
[1] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England
[2] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England
关键词
adenosine; cardiac volume; dilated cardiomyopathy; heart failure; oxygen; MAGNETIC-RESONANCE-SPECTROSCOPY; CORONARY-ARTERY-DISEASE; GRAPHICAL USER-INTERFACE; DILATED CARDIOMYOPATHY; FLOW-RESERVE; DOPPLER-ECHOCARDIOGRAPHY; FAILING HEART; METABOLISM; QUANTITATION; DYSFUNCTION;
D O I
10.1161/CIRCHEARTFAILURE.114.002169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Whether the myocardium in nonischemic heart failure experiences oxygen limitation remains a long-standing controversy. We addressed this question in patients with dilated cardiomyopathy (DCM) using a dual approach. First, we tested the changes in myocardial oxygenation between rest and stress states, using oxygenation-sensitive cardiovascular magnetic resonance. Second, we sought to assess the functional consequences of oxygen limitation at rest by measuring myocardial energetics before and after short-term oxygen supplementation. Methods and Results-Twenty-six subjects (14 DCM and 12 normal) underwent cardiac magnetic resonance imaging at 3 Tesla to assess cardiac volumes, function, oxygenation, and first-pass perfusion (0.03 mmol/kg Gd-DTPA bolus) at stress and rest (4-6 minutes IV adenosine, 140 mu g/kg per minute). Signal intensity change (SI Delta) and myocardial perfusion reserve index (MPRI) were measured from oxygenation and perfusion images, respectively. Furthermore, the effect of oxygen supplementation on resting myocardial energy metabolism was tested using P-31 MR spectroscopy, measuring PCr/ATP ratios in both groups at baseline and after 4 hours of oxygen via facemask in the DCM group. During stress, there were equivalent rises in rate pressure product in both groups (DCM, 7615% and normal, 79 +/- 9%; P=0.84). MPRI was significantly reduced in DCM (1.51 +/- 0.11 versus normal 1.86 +/- 0.10; P=0.03). However, there was no difference in oxygenation between groups: SI Delta in DCM 17 +/- 3% versus normal 20 +/- 2% (P=0.38). Furthermore, at a left ventricular segmental level, there was no correlation between oxygenation-sensitive SI Delta and MPRI (R=0.06; P=0.43). Resting PCr/ATP was reduced in DCM (1.66 +/- 0.07 versus normal 2.12 +/- 0.06; P=0.002). With oxygen supplementation, there was no change in PCr/ATP (1.61 +/- 0.08; P=0.58; Delta=0.04 +/- 0.05). There was also no effect of oxygen on systolic function (ejection fraction pre oxygen, 34 +/- 1%; post oxygen, 36 +/- 2%; P=0.46; Delta 2 +/- 1%). Conclusions-Our results demonstrate dissociation between microvascular dysfunction and oxygenation in DCM, suggesting that the impairment of perfusion is not sufficient to cause deoxygenation during stress. Cardiac energetics are unaffected by oxygen supplementation, indicating the absence of relevant myocardial hypoxia at rest. Our study suggests that novel treatments for nonischemic heart failure should focus on efforts to directly target cardiomyocyte function and metabolism rather than oxygen delivery and microvascular function.
引用
收藏
页码:1088 / 1093
页数:6
相关论文
共 50 条
  • [1] Drug Insight: statins for nonischemic heart failure - Evidence and potential mechanisms
    Lipinski, Michael J.
    Abbate, Antonio
    Fuster, Valentin
    Vetrovec, George W.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (04): : 196 - 205
  • [2] Drug Insight: statins for nonischemic heart failure—evidence and potential mechanisms
    Michael J Lipinski
    Antonio Abbate
    Valentin Fuster
    George W Vetrovec
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 : 196 - 205
  • [3] Progression of Myocardial Fibrosis in Nonischemic DCM and Association With Mortality and Heart Failure Outcomes
    Mandawat, Aditya
    Chattranukulchai, Pairoj
    Mandawat, Anant
    Blood, Alexander J.
    Ambati, Sindhoor
    Hayes, Brenda
    Rehwald, Wolfgang
    Kim, Han W.
    Heitner, John F.
    Shah, Dipan J.
    Klem, Igor
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (07) : 1338 - 1350
  • [4] Sex and Age Dimorphism of Myocardial Gene Expression in Nonischemic Human Heart Failure
    Fermin, David R.
    Barac, Ana
    Lee, Sangjin
    Polster, Sean P.
    Hannenhalli, Sridhar
    Bergemann, Tracy L.
    Grindle, Suzanne
    Dyke, David B.
    Pagani, Francis
    Miller, Leslie W.
    Tan, Sarah
    dos Remedios, Cris
    Cappola, Thomas P.
    Margulies, Kenneth B.
    Hall, Jennifer L.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2008, 1 (02) : 117 - U243
  • [5] The Role of Macrophages in Nonischemic Heart Failure
    Chen, Bijun
    Frangogiannis, Nikolaos G.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2018, 3 (02): : 245 - 248
  • [6] Nonischemic heart failure in diabetes mellitus
    Guha, Ashrith
    Harmancey, Romain
    Taegtmeyer, Heinrich
    CURRENT OPINION IN CARDIOLOGY, 2008, 23 (03) : 241 - 248
  • [7] Enhanced myocardial generation of oxygen radicals in heart failure
    Ide, T
    Tsutsui, T
    Kinugawa, S
    Utsumi, H
    Hattori, N
    Uchida, K
    Tagawa, H
    CIRCULATION, 1998, 98 (17) : 419 - 420
  • [8] Economic burden of nonischemic congestive heart failure: Evidence from PRAISE-2
    Kaul, P
    Davidson-Ray, L
    Cowper, P
    Liao, L
    Mark, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 535A - 535A
  • [9] ICD Implantation in Patients with Nonischemic Heart Failure
    Knackstedt, Christian
    Heymans, Stephane
    Brunner-La Rocca, Hans-Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (01): : 91 - 92
  • [10] The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
    Frangogiannis, Nikolaos G.
    CIRCULATION RESEARCH, 2019, 125 (01) : 117 - 146